Masahide Matsuyama Selected Research

Masahide Matsuyama Research Topics

Disease

16	Neoplasms (Cancer) 03/2010 - 05/2003
11	Carcinogenesis 03/2010 - 10/2005
10	Prostatic Neoplasms (Prostate Cancer) 03/2010 - 04/2004
10	Renal Cell Carcinoma (Grawitz Tumor) 03/2010 - 12/2003
8	Urinary Bladder Neoplasms (Bladder Cancer) 03/2010 - 05/2003
7	Testicular Neoplasms (Testicular Cancer) 03/2010 - 03/2004
6	Urologic Neoplasms (Urological Cancer) 03/2010 - 12/2003
6	Reperfusion Injury 03/2010 - 09/2003
5	Colorectal Neoplasms (Colorectal Cancer) 12/2009 - 10/2005
4	Carcinoma (Carcinomatosis) 06/2004 - 05/2003
3	Ischemia 07/2008 - 07/2008
2	Bone Resorption 04/2009 - 01/2008
2	Rheumatoid Arthritis 09/2008 - 01/2008
2	Necrosis 07/2008 - 12/2004
2	Neoplasm Metastasis (Metastasis) 01/2004 - 11/2003
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 07/2011
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2011
1	Proteinuria 07/2011
1	Transitional Cell Carcinoma 04/2009
1	Bone Diseases (Bone Disease) 04/2009
1	Osteoporosis 01/2008
1	Prostatic Intraepithelial Neoplasia 07/2007
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2007
1	Heart Arrest (Cardiac Arrest) 12/2004
1	Cystitis 11/2003

Drug/Important Bio-Agent (IBA)

15	Arachidonic Acid (Vitamin F)IBA 12/2009 - 11/2003
14	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2009 - 11/2003
12	Lipoxygenase (Lipoxygenase-1)IBA 07/2009 - 11/2003
9	LigandsIBA 03/2010 - 05/2003
7	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2010 - 05/2003
6	EnzymesIBA 12/2009 - 06/2004
5	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 03/2010 - 07/2007
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2009 - 10/2005
5	EicosanoidsIBA 07/2008 - 11/2003
4	PPAR gammaIBA 12/2008 - 05/2003
3	Telmisartan (Micardis)FDA Link 03/2010 - 08/2008
3	Lipoxygenase InhibitorsIBA 07/2005 - 11/2003
2	LeukotrienesIBA 07/2009 - 04/2009
2	OligodeoxyribonucleotidesIBA 12/2004 - 09/2003
2	Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA 01/2004 - 11/2003
1	Rituximab (Mabthera)FDA Link 07/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 07/2011
1	SteroidsIBA 07/2011
1	Phosphates (Orthophosphate)IBA 03/2010
1	Mevalonic Acid (Mevalonate)IBA 04/2009
1	Diphosphonates (Bisphosphonates)IBA 04/2009
1	NitrogenIBA 04/2009
1	Zoledronic Acid (Zometa)FDA Link 04/2009
1	Pamidronate (Aredia)FDA LinkGeneric 04/2009
1	Androgen Receptors (Androgen Receptor)IBA 04/2009
1	Cytostatic AgentsIBA 04/2009
1	Eicosapentaenoic AcidIBA 09/2008
1	Secretory Proteinase Inhibitory ProteinsIBA 07/2008
1	CytokinesIBA 07/2008
1	Leukocyte Elastase (Neutrophil Elastase)IBA 07/2008
1	Prostaglandins EIBA 01/2008
1	InterleukinsIBA 01/2008
1	Interleukin-1 (Interleukin 1)IBA 01/2008
1	ProstaglandinsIBA 01/2008
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2004
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2004
1	Peptides (Polypeptides)IBA 02/2004
1	BromidesIBA 11/2003
1	Thromboplastin (Tissue Factor)IBA 09/2003
1	Antisense OligonucleotidesIBA 09/2003
1	PPAR alphaIBA 05/2003

Therapy/Procedure

2	Therapeutics 07/2011 - 06/2004
2	Kidney Transplantation 07/2011 - 07/2008
1	Plasma Exchange 07/2011
1	Blood Component Removal (Apheresis) 07/2011
1	Transplantation 12/2004
1	Ureterostomy 06/2004
1	Lymph Node Excision (Lymph Node Dissection) 06/2004